BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Alliances
IXICO Announces Enhanced Contracts With Two Pharmaceutical Company Customers In Huntington's Disease 11/26/2014
Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma 11/26/2014
$1 Billion Oncology Alliance Between Menarini Group & Oxford BioTherapeutics Initiates First-In-Human Study Of Enhanced Antibody For Treatment Of Acute Myeloid Leukemia 11/25/2014
University of California, San Francisco (UCSF) And OncoSec Medical Inc. Collaborate To Evaluate Investigational Combination Of ImmunoPulse And Anti-PD-1 Treatment 11/25/2014
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With Pharmaceutics International, Inc. 11/25/2014
Parent Project Muscular Dystrophy And Santhera Pharmaceuticals AG (SANN.SW) Team Up On Benefit/Risk Study In Duchenne 11/25/2014
Paragon Bioservices Wins NIH Contract For Design & Scale-Up Manufacturing Of rhE -Selectin Protein 11/25/2014
Zymeworks Announces Research Collaboration With Dr. Dennis J. Slamon And University of California, Los Angeles (UCLA) 11/25/2014
Bristol-Myers Squibb Company (BMY) And Five Prime Therapeutics, Inc. (FPRX) Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types 11/24/2014
Drug Giant Merck & Co. (MRK) Buys Rights To NewLink Genetics Ebola Vaccine rVSV-EBOV 11/24/2014
GlaxoSmithKline (GSK) Shareholders To Vote On Novartis AG (NVS) Deal On Dec. 18 11/24/2014
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M 11/24/2014
Omnicare, Inc. (OCR) And McKesson Corporation Expand Distribution Agreement 11/24/2014
Sevion Therapeutics Announces Chimerasome Research Agreement 11/24/2014
Boston Therapeutics, Inc. and Advance Pharmaceutical Expand Agreement To Market Sugardown® In 12 Additional Countries In Asia 11/24/2014
MRC Technology And Yabao Pharmaceuticals Announce Exclusive Partnership In China To Develop Novel Therapeutics For Parkinson’s Disease 11/24/2014
Chembio Diagnostics, Inc. (CEMI.OB) Signs Agreement With CDC Contractor To Develop A Multiplex Point-Of-Care Test For Influenza Immunity 11/24/2014
Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million 11/21/2014
Coquí RadioPharmaceuticals Inks Deal With INVAP 11/21/2014
Yabao Pharmaceuticals And MRC Technology Announces Exclusive China Partnership 11/21/2014
The Dow Chemical Company (DOW) And Third Point Reach Agreement 11/21/2014
LabCorp Completes Acquisition Of LipoScience, Inc. 11/21/2014
Lincoln Park Doubles Down On Oncology With $55M Galena Biopharma  (GALE) Bet 11/21/2014
Ironwood Pharmaceuticals (IRWD) Earns $15 Million Milestone From Astellas Pharma Inc. (ALPMY) 11/20/2014
OncoSec Medical Inc. And University of Washington Enter Sponsored Research Agreement 11/20/2014
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/20/2014
California Institute of Technology, City of Hope Collaborate To Advance Scientific Breakthroughs, Medical Research 11/20/2014
Anthera, Inc. And Patheon Inc. (PTI.TO) Sign Manufacturing Agreement For Liprotamase Phase 3 Registration Trial 11/20/2014
PharmAthene, Inc. (PIP) Fulfills Valortim IDIQ Contract 11/20/2014
STALLERGENES And ActoGeniX To Develop An Innovative New Class Of Oral Allergy Treatments 11/20/2014
Ipsen (IPN.PA) And CNRS Create The "Archi-Pex" Joint Research And Innovation Lab, In Collaboration With The University Of Rennes 1 And CEA 11/20/2014
Aspira Scientific To Distribute Nagase's Unnatural Amino Acids For Next-Generation Drug Candidate Development 11/19/2014
Royalty Pharma Buys Royalties On Vertex Pharmaceuticals Incorporated (VRTX) Drugs For $3.3 Billion 11/19/2014
Transgenomic, Inc. (TBIO) Collaborates With Researchers To Advance Understanding Of Genetic Disease Tuberous Sclerosis 11/19/2014
Oncore Announces Exclusive HBV Research Collaboration With The Baruch S. Blumberg Institute 11/19/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/19/2014
Regenicin, Inc. Enters Into Asset Purchase Agreement With Amarantus Bioscience Holdings, Inc. 11/19/2014
U.S. Agency for International Development, Broad Institute, And Illumina, Inc. (ILMN) Form A Public-Private Partnership Combating The Ebola Epidemic In West Africa 11/19/2014
NYU Langone Medical Center And Lutheran Medical Center To Affiliate 11/19/2014
Ikaria Inc. And Lee's Pharmaceutical Announce Strategic Partnership For The Registration And Commercialization Of Ikaria's INOMAX Total Care Package In The People's Republic Of China, Hong Kong, Macau And Taiwan 11/19/2014
BioMed Realty Trust And Broad Institute Form Strategic Partnership To Promote Innovation And Collaboration Within The Life Science Industry 11/19/2014
ARUP Laboratories And Seattle Children's Hospital Collaborate On Utilization Management Via Seattle Children's Innovative PLUGS Program 11/19/2014
StayinFront And QPharma, Inc. Partner To Deliver An Unrivaled Combination Of Technology, Services And Regulatory Expertise To Life Sciences Companies 11/19/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
Clovis Oncology (CLVS) Rises On News Of GlaxoSmithKline (GSK) Oncology Collaboration 11/18/2014
Humana, Inc. (HUM) Partners With Bill Pay At CVS/Pharmacy To Provide Convenient, In-Store Health Insurance Payment Option 11/18/2014
Ipsen (IPN.PA) And Salk Institute for Biological Studies Renew Their Agreement For Discovery Research In Medical Sciences 11/18/2014
Omnicell And King Faisal Specialist Hospital And Research Centre Collaborate To Deliver Excellence In Automation 11/18/2014
Generex Biotechnology Corporation (GNBT) Announces Collaboration On Medicinal Cannabis 11/18/2014
MYMETICS Corporation Announces New Collaboration To Advance The Development Of An Innovative Malaria Vaccine Candidate 11/18/2014
N-of-One Selected By BloodCenter Of Wisconsin To Provide Patient-Specific Molecular Interpretation For Next Generation Sequencing Of Hematologic Malignancies 11/18/2014
A*STAR’s Genome Institute of Singapore Strengthens Its Genome Sequencing Capabilities Through Collaboration With BT 11/18/2014
Vivex Biomedical Announces Definitive Agreement With The University of Miami Marietta, GA/Miami, FL 11/18/2014
Pfizer (PFE), Merck KGaA (MKGAF.PK) Strike A $2.9B Deal To Develop Cancer Tumor Treatment 11/18/2014
TapImmune Inc. (TPIV) Announces Phase 2 Clinical Trials Collaboration With VGTI Florida To Advance Breast And Ovarian Cancer Vaccines 11/18/2014
MiNA Completes Exclusive License Agreement With University of California, San Francisco (UCSF) 11/18/2014
Edge Therapeutics Announces Multi-Year Research Collaboration With Leading Academic Medical Center 11/18/2014
OncoSec Medical Inc. And Plexxikon Inc. Collaborate To Explore Combination Immunotherapy In Preclinical Tumor Studies 11/18/2014
Allied-Bristol Life Sciences Forms Strategic Partnership With Synergy Partners R&D Solutions To Advance Biopharmaceutical Innovations From Leading U.S. Academic Research Institutions 11/18/2014
Inovio Pharmaceuticals (INO), Roche (RHHBY) Terminated Collaboration To Co-develop INO-5150 11/17/2014
Tekmira (TKMR) Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals (DRNA) 11/17/2014
Geron Corporation (GERN) Signs Top Drug Over To Johnson & Johnson (JNJ) In Deal Worth $935 Million 11/17/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Denies Calling Off JV With Merck & Co. (MRK) 11/17/2014
Baring Asia Says Agrees To Buy Japan Drugmaker Bushu From Tokio Marine 11/17/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Aspen For BRINAVESS® In South Africa 11/17/2014
Bone Therapeutics & Kasios Collaborate On Novel Product For Optimisation Of Spinal Fusion Procedures 11/17/2014
Organic Vaccines Plc - Agreements With NIH And National Cancer Institute 11/17/2014
NovaBay Pharmaceuticals, Inc. (NBY) Signs Distribution Agreement With McKesson Corporation For i-Lid Cleanser 11/17/2014
RetroSense Therapeutics Signs License Agreement With Massachusetts General Hospital, Expanding Its Optogenetics Intellectual Property Portfolio 11/17/2014
Merz Pharma Canada Ltd. Announces Exclusive Distribution Arrangement With Ulthera 11/17/2014
VistaGen Therapeutics, Inc. Signs Letter Of Intent With National Institute of Mental Health For NIH-Sponsored Phase 2 Clinical Study Of AV-101 In Major Depressive Disorder 11/17/2014
Cellmid Signs Evaluation and Option to License Agreement With Zoetis (ZTS) 11/17/2014
Medidata Solutions, Inc. Collaborates With GlaxoSmithKline (GSK) On Mobile Health Initiative To Test Novel Technology For Clinical Trial Optimization 11/17/2014
PDL BioPharma, Inc. (PDLI) Gets $30.3 Million To Conclude Contract With AxoGen, Inc. (AXGN) 11/14/2014
Boehringer Ingelheim Corporation, Wellpoint, And HealthCore Announce First Project Under Multi-Year Research Collaboration 11/14/2014
Human Longevity Inc. Signs Collaborative Agreement With King's College London To Access Twinsuk Registry 11/13/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option 11/13/2014
Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device 11/13/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Medgenics, Inc. Announces Rare & Orphan Disease Research Collaboration With The Children's Hospital of Philadelphia 11/13/2014
AstraZeneca PLC (AZN) And Isis Pharmaceuticals, Inc. (ISIS) To Co-Develop Targeted Oligonucleotide Delivery Methods 11/13/2014
Unilife Corporation (UNIS) and Flextronics (FLEX) Enter Into Global Strategic Alliance 11/13/2014
Harrington Discovery Institute At University Hospitals, Cleveland, Forms Affiliation With University of Oxford To Create An International Initiative To Drive Early-Stage Drug Discovery And Development 11/13/2014
Onxeo Confirms Receipt Of The $25M Milestone Payment On Beleodaq® 11/13/2014
The Dow Chemical Company (DOW) Provides Update Regarding Strategic Investments In Its Plastics Franchise In The Americas 11/13/2014
University of British Columbia And Tilray Partner For Canada’s First PTSD Cannabis Study 11/13/2014
Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference 11/13/2014
AVEO Oncology (AVEO), Ophthotech Corporation (OPHT) Forge Research, License Deal Worth $105 Million+ 11/12/2014
Global Biopharmaceutical Company UCB Expands Real Estate Services Relationship With JLL 11/12/2014
ABIVAX Signs Agreement With The Finlay Institute To Commercialise Meningococcal And Typhoid Vaccines In Asia And Latin America 11/12/2014
Enterome Enters Into A Microbiome-Based Development Collaboration With AbbVie (ABBV) In Crohn's Disease 11/12/2014
Roche (RHHBY) Teams Up With LabCentral To Support Biotech Startups 11/12/2014
Funakoshi Co. To Distribute Reachbio Research Labs Human Primary Cell Products In Japan 11/12/2014
Presage Biosciences Expands Collaboration With Takeda (TKPYY) For CIVO™ Technology To Assess Cancer Drugs Directly In Solid Tumors 11/12/2014
Drugmakers Like Johnson & Johnson (JNJ), Emergent BioSolutions (EBS), And Mapp Biopharmaceutical Stand To Gain Ebola Contracts Worth $2 Billion 11/11/2014
Support For SBC's OI Challenge From Drug Discovery Specialist Astex Pharmaceuticals (ASTX) 11/11/2014
ArQule, Inc. (ARQL) Announces Collaboration With NIH For Clinical Development Of ARQ 092 In Proteus Syndrome 11/11/2014
Stellar Biotechnologies, Inc. And Araclon Biotech Sign Exclusive KLH Supply Agreement For Clinical Trials In Alzheimer's Active Immunotherapies 11/11/2014
GE Healthcare And Takeda Pharmaceutical Co. Ltd. (TKPYY) Join Forces To Develop Therapeutic Drugs To Target Liver Diseases 11/11/2014
BioAtla Partners With BioDuro, LLC To Advance Two Proprietary Antibody Therapeutics In China 11/11/2014
Ascletis, Inc. Gains Exclusive China Market Rights From Presidio Pharmaceuticals, Inc. To Clinical Stage Hepatitis C Virus (HCV) NS5A Inhibitor PPI-668 11/10/2014
Pharco Pharmaceuticals Licenses Clinical Stage Hepatitis C Virus (HCV) NS5A Inhibitor PPI-668 From Presidio Pharmaceuticals, Inc. 11/10/2014
ScinoPharm And Nanjing King-Friend Biochemical Pharmaceutical Team Up To Jointly Enter The Chinese Market For New Drugs 11/10/2014
Cartagenia Partners With CollabRx, Inc. To Provide Pathology Laboratories And Cancer Centers Access To Personalized Information On Therapeutic Options 11/10/2014
iBio, Inc. (IBIO) Grants Caliber Biotherapeutics License For Production Of Antibodies Targeting Ebola 11/10/2014
Cambio Ltd To Sell BioPointe Scientific’s World-Class Lab Consumables 11/7/2014
Tekmira (TKMR) Rises On Deal To Produce Ebola Drug For U.S. Troops 11/7/2014
Mylan Inc. (MYL) Signs Strategic Alliance Agreement With Walt Disney Parks And Resorts To Enhance Access To EpiPen® (epinephrine) Auto-Injectors 11/7/2014
Vectura Group plc (VEC.L) VR315 U.S. Development Milestone 11/7/2014
Idera Pharmaceuticals, Inc. (IDRA) And Parent Project Muscular Dystrophy Announce Collaboration To Advance New Treatment Approach For Duchenne Muscular Dystrophy 11/7/2014
Felicitex Therapeutics And Selvita Initiate Strategic Collaboration To Target Cancer Quiescence 11/7/2014
Isis Pharmaceuticals, Inc. (ISIS) Pockets $10 Million Milestone Payment From Biogen Idec (BIIB) 11/6/2014
Janssen Research & Development Collaborates For Continued Evaluation Of Multidrug-Resistant Tuberculosis Treatment Regimens With SIRTURO® (bedaquiline) 11/6/2014
BIND Therapeutics (BIND) Announces Agreement With Merck & Co. (MRK) To Develop Targeted Accurin™ Nanomedicines For Oncology 11/6/2014
Hitachi, Ltd. (HIT) And Qatar University Enter Into A Comprehensive Industry-University Collaboration Agreement Concerning Environmental And Energy Efficiency Technologies In The Infrastructure Systems Field 11/6/2014
World Fusion And Lumenogix Announce Global Strategic Partnership 11/6/2014
Otonomy, Inc. (OTIC) Obtains Rights To Gacyclidine Data From Ipsen (IPN.PA) To Support Development Of OTO-311 As A Treatment For Tinnitus 11/6/2014
National Heart Research Institute Singapore And Thermo Fisher Scientific (TMO) Teams Up To Further Enhance Stem Cell Research Techniques 11/6/2014
Lundbeck Inc. (LUN.CO) Partners With The Hereditary Disease Foundation, Pledges Five Additional Years Of Support For Build Hope For Huntington’s Disease Campaign 11/6/2014
Cocoon Biotech To Explore New Treatments For Joint Disease Using Silk Biomaterial Platform Developed At Tufts University 11/5/2014
Astellas Pharma Inc. (ALPMY), Proteostasis Therapeutics, Inc. Forge $1.2 Billion Genetic Disease Drug Pact 11/5/2014
Invetech And Argos Therapeutics, Inc. (ARGS) Announce Agreement To Support Global Production Of Fully Personalized Immunotherapies 11/5/2014
AstraZeneca PLC (AZN) And Pharmacyclics, Inc. (PCYC) Enter Clinical Trial Collaboration To Evaluate IMBRUVICA® In Hematologic Cancers 11/5/2014
GenVec Inc. (GNVC) Achieves Milestone In Hearing And Balance Collaboration 11/5/2014
Advinus Therapeutics (P) Ltd., A TATA Enterprise, Meets Milestone In Drug Discovery Alliance 11/5/2014
OrthoAccel Technologies, Inc. First To Partner With Focus Ortho, Integrating Acceledent Fasttrac Usage Report Into Innovative Software 11/5/2014
Medical Prognosis Institute And Alion Pharmaceuticals Establish Partnership To Develop Drug Response Predictors For Ion Channel Inhibitors In Oncology 11/5/2014
Charles River Laboratories (Massachusetts)'s Early Drug Discovery Business And CHDI Foundation Extend Huntington’s Disease Collaboration 11/5/2014
Sunovion Pharmaceuticals Inc. And The COPD Foundation Expand COPD Together Campaign To Empower Family Caregivers 11/5/2014
AstraZeneca PLC (AZN) Strengthens Cancer Biz With Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC) Deals 11/4/2014
Dana-Farber Cancer Institute And Astellas Pharma Inc. (ALPMY) Announce Research Collaboration 11/4/2014
Imprimis Pharmaceuticals (immy) Signs Distribution Agreement To Bring Go Dropless™ Proprietary Formulations To Ophthalmologists In Puerto Rico 11/4/2014
Sagent Pharmaceuticals, Inc. Reports Third Quarter 2014 Financial Results 11/4/2014
Abide Therapeutics Announces A Collaborative Agreement With The University of Oxford 11/4/2014
AstraZeneca PLC (AZN) And Pharmacyclics, Inc. (PCYC) Enter Immuno-Oncology Clinical Trial Collaboration With IMBRUVICA® In Solid Tumors 11/4/2014
Broad Institute And University Of California Team Awarded National Cancer Institute Cancer Genomics Cloud Pilot Contract 11/4/2014
LEO Pharma And Japan Tobacco Enter Into License Agreement For Novel JAK inhibitor Drug Candidate 11/4/2014
Tauriga Sciences Inc. (TAUG) Signs MOU To Distribute And Sell Natural Wellness Products Throughout Asia 11/4/2014
Vivione Biosciences Announces Clinical Pilot With The Cleveland Clinic Department Of Pathology 11/4/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Increases Efficiency And Reduces Costs Through Expanded Partnership With Emerson Group 11/4/2014
ex scientia Ltd. Partners With Sunovion Pharmaceuticals Inc. To Research New Medicines For Psychiatric Disorders 11/4/2014
Medidata Solutions, Inc. And PPD, Inc. (PPDI) Partner To Offer New Approach To Risk-Based Monitoring 11/4/2014
Pharming Group (PHGUF.PK) Confirms Receipt Of US$20 Million Milestone Payment From Salix Pharmaceuticals, Ltd. (SLXP) 11/4/2014
Bristol-Myers Squibb Company (BMY) Strikes Deal Worth $444 Million With Galecto Biotech 11/4/2014
Carlina Technologies Signs A Partnership Agreement With Genbiotech To Develop A Sustained-Release Protein Formulation For Cartilage Repair 11/4/2014
Genmab A/S (GEN.CO) Moves Cancer Drug Pact To Novartis AG (NVS) From GlaxoSmithKline (GSK) 11/4/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Walks Away From Intra-Cellular Therapies, Inc. CNS Disorders Deal 11/3/2014
Bone Marrow Transplant Technology Commercialisation Advances With Cytomatrix Deal 11/3/2014
Hemispherx Biopharma (HEB) And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Collaborate On Alferon® And Ampligen® Against The Ebola Virus 11/3/2014
Lonza Group Ltd. (LZAGY.PK) And Celladon Corporation Establish A Strategic Commercial Manufacturing Collaboration For MYDICAR® 11/3/2014
Myriad Genetics, Inc. (MYGN) And AbbVie (ABBV) Sign Expanded Agreement For Tumor Bracanalysis CDx™ 11/3/2014
BioCon Limited (BIOCON.NS) Expands Its Strategic Partnership With CytoSorbents, Inc. For Cytosorb® To Treat SIRS And Cardiac Surgery Patients 11/3/2014
New York Blood Center, Prophylix Pharma AS, And BloodCenter Of Wisconsin Collaborate To Fight Devastating Neonatal Bleeding Disorder 11/3/2014
SCYNEXIS, Inc. (SCYX) Enters Into Worldwide Agreement With Waterstone Pharmaceutical For The Development And Commercialization Of SCY-635 For Viral Diseases 11/3/2014
Clinical Network Services (CNS) Signs Cooperative Agreement With BD Consultancy 11/3/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $5 Million In Milestone Payment From GlaxoSmithKline (GSK) For Advancement Of ISIS-GSK5 Rx 11/3/2014
Sangui BioTech International Inc. (SGBI): Laboratorios Silanes Start Marketing Granulox In Mexico 11/3/2014
Global Bioenergies Proceeds With Another 100,000 Euro Draw Down On Its Standby Equity Distribution Agreement 11/3/2014
Zogenix, Inc. (ZGNX) And Purdue Pharma L.P. Exchange Waivers Of Regulatory Exclusivity For Extended-Release Hydrocodone Products 10/31/2014
Medidata Solutions, Inc. Selected By ASLAN Pharmaceuticals As Enterprise-Wide Technology Platform For Enhancing Clinical Development 10/31/2014
MediGene AG (MDGEF.PK)'s Licensee Enters Promotion Agreement To Expand Veregen® Product Sales In The United States 10/30/2014
Chugai Pharmaceutical Co., Ltd. (Japan) Licenses ISPRI/Optimatrix Platform From EpiVax, Inc. For De-Risking Biologics 10/30/2014
Medivir AB (MVRBF) And County Councils Conclude Agreement On Olysio®-Based Treatment For Hepatitis C 10/30/2014
Transgenomic, Inc. (TBIO) And University of Melbourne Collaborate To Further Validate Ability Of Multiplexed ICE COLD-PCRTM To Enable Personalized Cancer Treatment 10/30/2014
Bristol-Myers Squibb Company (BMY) And Lonza Group Ltd. (LZAGY.PK) Expand Manufacturing Agreement 10/30/2014
Eli Lilly (LLY), Boehringer Mannheim Corporation Revise Terms Of Diabetes Drugs Alliance 10/29/2014
Celerion Completes Recapitalization Through Investment By MTS Capital Health Partners 10/29/2014
Clean TeQ Holdings Limited (ASX:CLQ) Teams Up With Queensland University of Technology's Institute For Future Environments 10/29/2014
Xencor Regains All Rights From Amgen (AMGN) To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes 10/29/2014
Imprimis Pharmaceuticals (immy) Enters Into License Agreement For Patented Urology Formulation 10/29/2014
Polyplus Transfection And Blue Sky Bioservices Sign A Research And Commercial License Agreement For Use Of PEI-Based Transfection Technologies 10/29/2014
Bristol-Myers Squibb Company (BMY) Forges $475 Million Pact For Rights To f-Star's Cancer Drug 10/28/2014
Amgen (AMGN), Ono Pharmaceutical Company, Ltd., Sanofi (SAN.PA) Team Up With Academia On Proteins Project 10/28/2014
Amunix, Inc. And PolyPeptide Laboratories Inc. Enter Into Partnership To Produce XTEN™ Peptide Conjugates For Evaluation By Third Parties For Pharmaceutical Therapeutics 10/28/2014
N-of-One Selected By Intermountain Healthcare To Provide Deep Clinical Interpretation For Cancer Genomics 10/28/2014
Janssen Signs Translational Medicine MOU With Shanghai Ruijin Hospital 10/28/2014
Molecular Devices, Inc. (MDCC) Partners With Roche to Develop Custom Ruthenium Nano-TRF® Detection Platform 10/28/2014
Enerkem Announces New Project Partnership In China 10/28/2014
BioDelivery Sciences International (BDSI)To Develop A Long-Acting Injectable Depot Formulation Of Buprenorphine With Evonik Industries For Use In Opioid Dependence And Pain 10/28/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Entry Into $20 Million "At-The-Market" Equity Distribution Agreement With Canaccord Genuity Inc. 10/28/2014
Nagoya University’s ITbM, Japan, Licenses Cresset’s Computational Chemistry Software To Accelerate Their Research 10/28/2014
KineMed, Inc. And US Army Announce Collaboration To Measure Muscle Function And Response During Military Operations 10/28/2014
Wolters Kluwer Health Partners With Philips Clinical Informatics To Revolutionize Access To Clinical Decision Support In Brazil 10/28/2014
Triphase Accelerator Announces Expanded Collaboration With Celgene (CELG) 10/28/2014
Triphase Accelerator Accelerator Corporation Announces New Collaboration With Celgene (CELG) 10/28/2014
PharmAbcine Announces Global Licensing Deal With Triphase Accelerator For VEGFR-2/TIE 2 Bi-Specific Antibody 10/28/2014
ProtoKinetix Inc. (PKTX.OB) Announces Termination Of Intrepid Agreement 10/28/2014
Iroko Pharmaceuticals Announces New Strategic Agreement To Commercialize ZORVOLEX® In Australia And New Zealand 10/28/2014
Pain Therapeutics (PTIE) Tanks As Pfizer (PFE) Walks Away From Remoxy® Deal 10/27/2014
Cellular Dynamics International Awarded $1.2 Million National Eye Institute Contract For Developing Patient-Derived Stem Cells In Gear-Up For Age-Related Macular Degeneration Trial 10/27/2014
Calchan And Galapagos NV (GLPG.BR) Collaborate On Osteoarthritis Pain Research 10/27/2014
PlasmaTech Biopharmaceuticals Signs Expanded MuGard Licensing Agreement With Norgine For Australia And New Zealand Territories 10/27/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Expand ADASUVE® Partnership 10/27/2014
Clontech Laboratories, Inc. Licenses CRISPR/Cas9 Technology From The Broad Institute 10/27/2014
pSivida Corp (PSDV) Pockets $25 Million Milestone Payment 10/27/2014
Mersana Therapeutics, Inc. And Takeda (TKPYY) Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate 10/27/2014
Oxford University And Pronova Partner To Bring First Proton Research Center To The United Kingdom 10/27/2014
Mersana Therapeutics, Inc. And Takeda Pharmaceutical Co. Ltd. (TKPYY) Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate 10/27/2014
The Dow Chemical Company (DOW) Licenses Simulations Plus (SLP) Software To Assist With Toxicology And Environmental Research 10/27/2014